Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M. Mahmoud Fahmy Mansour"'
Autor:
M. Kato, Hiroaki Dobashi, K. Ueeda, Nobuyuki Miyatake, Norimitsu Kadowaki, Tomohiro Kameda, M. Mahmoud Fahmy Mansour, T. Miyagi, Hiromi Shimada, Shusaku Nakashima, R. Wakiya
Publikováno v:
Lupus. 28:826-833
ObjectivesWe investigated the effect of hydroxychloroquine (HCQ) on S100A8 and S100A9 serum levels in systemic lupus erythematosus (SLE) patients with low disease activity receiving immunosuppressants.MethodsSELENA-SLEDAI, Cutaneous Lupus Erythematou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611adc6d6bc20b8d3ce1195066c6d016
https://doi.org/10.1177/0961203319846391
https://doi.org/10.1177/0961203319846391
Autor:
Y. Ushio, M. Kato, Hiroaki Dobashi, M. Mahmoud Fahmy Mansour, Hiromi Shimada, Tomohiro Kameda, K. Sugihara, R. Wakiya, Shusaku Nakashima
Publikováno v:
Annals of the Rheumatic Diseases. 80:1249.2-1249
Background:Connective tissue disease-associated pulmonary hypertension (CTD-PH) is constructed by a variety of pathologies, including cardiac, pulmonary, and vascular involvement, as well as immune abnormalities. Because of its various constructs, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acca9265810beec392df68276895ca82
https://doi.org/10.1136/annrheumdis-2021-eular.2765
https://doi.org/10.1136/annrheumdis-2021-eular.2765
Autor:
Hiromi Shimada, M. Mizusaki, R. Senba, Shusaku Nakashima, R. Wakiya, M. Mahmoud Fahmy Mansour, Hiroaki Dobashi, T. Miyagi, K. Sugihara, M. Kato, Tomohiro Kameda, Y. Ushio
Publikováno v:
Annals of the Rheumatic Diseases. 80:1223-1223
Background:It is known that most of ANCA-associated vasculitis (AAV) patients are elderly. A cohort study showed that the mean age of onset was 71.1 years, especially in patients with microscopic polyangiitis (MPA)1). However, the characteristics and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7a2ae7772a2b87c589b015017d34f61
https://doi.org/10.1136/annrheumdis-2021-eular.1367
https://doi.org/10.1136/annrheumdis-2021-eular.1367
Autor:
K. Sugihara, M. Mahmoud Fahmy Mansour, Hiroaki Dobashi, Y. Ushio, M. Kato, Tomohiro Kameda, Shusaku Nakashima, R. Wakiya, Hiromi Shimada
Publikováno v:
Annals of the Rheumatic Diseases. 80:513.1-513
Background:Recently, there are many reports from Japan about methotrexate associated lymphoproliferative disorder (MTX-LPD). We are investigating the predictive factor of spontaneous regression (SR) in MTX-LPD. On the other hand, FDG-PET/CT is used f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83a0a725028af7cf47c097c00271d485
https://doi.org/10.1136/annrheumdis-2021-eular.2812
https://doi.org/10.1136/annrheumdis-2021-eular.2812
Autor:
Y. Ushio, R. Senba, M. Kato, Tomohiro Kameda, M. Mizusaki, Hiroaki Dobashi, Hiromi Shimada, T. Miyagi, K. Sugihara, R. Wakiya, K. Ueeda, M. Mahmoud Fahmy Mansour, Shusaku Nakashima
Publikováno v:
Annals of the Rheumatic Diseases. 80:961.1-961
Background:Apremilast, the small-molecule phosphodiesterase (PDE) -4 inhibitor, was approved for the treatment of recurrent oral ulcers associated with Behcet’s disease (BD) in Japan from September 2019, following the success of the phase 3 RELIEF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9686ec5d7addddb9469bc5049b85fb11
https://doi.org/10.1136/annrheumdis-2021-eular.2772
https://doi.org/10.1136/annrheumdis-2021-eular.2772
Autor:
Hiroaki Dobashi, Y. Ushio, Hiromi Shimada, Shusaku Nakashima, M. Mahmoud Fahmy Mansour, Tomohiro Kameda, T. Miyagi, K. Sugihara, M. Kato, R. Wakiya
Publikováno v:
Annals of the Rheumatic Diseases. 80:1437.1-1437
Background:Previous reports showed that connective tissue disease (CTD) have a high risk for adverse pregnancy outcomes (APOs) such as preterm birth, light-for-date, or preeclampsia1). It was revealed that these APOs were associated with high disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f813b78228cc34da4fdafed8256b8603
https://doi.org/10.1136/annrheumdis-2021-eular.2479
https://doi.org/10.1136/annrheumdis-2021-eular.2479
Autor:
R. Wakiya, Y. Ushio, M. Mizusaki, Hiroaki Dobashi, K. Ueeda, M. Mahmoud Fahmy Mansour, M. Kato, T. Miyagi, Shusaku Nakashima, K. Sugihara, Hiromi Shimada, Tomohiro Kameda, R. Senba
Publikováno v:
Annals of the Rheumatic Diseases. 80:1169.2-1170
Background:In systemic lupus erythematosus(SLE), a higher frequency of atherosclerotic lesions is associated with a poor life prognosis (1). Hydroxychloroquine (HCQ) has been reported to improve the prognosis of life and dyslipidemia in SLE (2), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a24ca522dc4b50efbab0bcef7abbf18
https://doi.org/10.1136/annrheumdis-2021-eular.2362
https://doi.org/10.1136/annrheumdis-2021-eular.2362
Autor:
R. Wakiya, Hiromi Shimada, Hiroaki Dobashi, Shusaku Nakashima, M. Mahmoud Fahmy Mansour, T. Miyagi, K. Sugihara, Tomohiro Kameda, M. Kato, Y. Ushio
Publikováno v:
Annals of the Rheumatic Diseases. 79:1544.2-1544
Background:Rituximab(RTX) and Cyclophosphamide(CY) has been indicated for ANCA-associated vasculitis(AAV) as remission induction therapy. However, older age and renal disfunction were independent predictor of treatment related adverse effects in remi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cf90aace4c715a5dd5174a5a5d07eab
https://doi.org/10.1136/annrheumdis-2020-eular.5377
https://doi.org/10.1136/annrheumdis-2020-eular.5377
Autor:
Masayuki Inoo, M. Kato, Hiroaki Dobashi, Tomohiro Kameda, I. Onishi, Shusaku Nakashima, R. Wakiya, Y. Ushio, M. Mahmoud Fahmy Mansour, Hiromi Shimada, Noriyuki Kurata, T. Miyagi, K. Sugihara
Publikováno v:
Annals of the Rheumatic Diseases. 79:609.2-609
Background:Lymphoproliferative disorders (LPD) that develop in rheumatoid arthritis (RA) patients treated with MTX (MTX-LPD) is one of the important complications for RA patients. We have previously epidemiologically demonstrated an association betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d16d919d4a8e6a1c9d8920a0a06d42cb
https://doi.org/10.1136/annrheumdis-2020-eular.5309
https://doi.org/10.1136/annrheumdis-2020-eular.5309
Autor:
Hiromi Shimada, Y. Ushio, T. Miyagi, K. Sugihara, M. Mahmoud Fahmy Mansour, R. Wakiya, Tomohiro Kameda, M. Kato, Hiroaki Dobashi, Shusaku Nakashima
Publikováno v:
Annals of the Rheumatic Diseases. 79:1592.2-1593
Background:Systemic sclerosis (SSc) have various organ involvements including pulmonary hypertension (PH), digital ulcers (DU), and interstitial lung disease (ILD). On the other hand, Nailfold capillary (NFC) abnormalities (enlarged/giant capillaries
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e7e051a38b15dbbaf9c7ca371658a03
https://doi.org/10.1136/annrheumdis-2020-eular.5623
https://doi.org/10.1136/annrheumdis-2020-eular.5623